Article Details
Retrieved on: 2021-05-14 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Friday unveiled its draft evidence report on JAK inhibitors and monoclonal antibodies used to treat atopic dermatitis, otherwise known as eczema.
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here